GO
Loading...

Amgen Inc

More

  • Final Glance: Biotechnology companies Friday, 24 Oct 2014 | 6:35 PM ET

    Amgen Inc. rose$. 01 or percent, to $147.26. Biogen Idec rose $5.61 or 1.8 percent, to $321.67. Celgene Corp. rose $2.84 or 2.8 percent, to $103.24.

  • Oct 24- Amgen Inc, one of the world's largest biotechnology companies, will unveil next week its first strategy update since early 2013, but few expect a major shift like the split-up recently proposed by Daniel Loeb's Third Point hedge fund. In a letter to investors on Tuesday, Loeb said Amgen has "all the hallmarks of a hidden value situation" and should divide...

  • Midday Glance: Biotechnology companies Friday, 24 Oct 2014 | 1:17 PM ET

    Amgen Inc. fell $1.41 or 1.0 percent, to $145.84. Biogen Idec rose $3.09 or 1.0 percent, to $319.15. Celgene Corp. rose $2.15 or 2.1 percent, to $102.55.

  • Early Glance: Biotechnology companies Friday, 24 Oct 2014 | 10:40 AM ET

    Amgen Inc. fell$. 43 or. 3 percent, to $146.82. Biogen Idec rose $1.58 or. 5 percent, to $317.64. Celgene Corp. rose $1.93 or 1.9 percent, to $102.33.

  • Final Glance: Biotechnology companies Thursday, 23 Oct 2014 | 6:02 PM ET

    Amgen Inc. rose $3.61 or 2.5 percent, to $147.25. Biogen Idec rose $6.99 or 2.3 percent, to $316.06. Celgene Corp. rose $5.64 or 6.0 percent, to $100.40.

  • Midday Glance: Biotechnology companies Thursday, 23 Oct 2014 | 1:51 PM ET

    Amgen Inc. rose $3.75 or 2.6 percent, to $147.39. Biogen Idec rose $7.67 or 2.5 percent, to $316.74. Celgene Corp. rose $5.82 or 6.1 percent, to $100.58.

  • Early Glance: Biotechnology companies Thursday, 23 Oct 2014 | 11:56 AM ET

    Amgen Inc. rose $3.58 or 2.5 percent, to $147.22. Biogen Idec rose $4.73 or 1.5 percent, to $313.80. Celgene Corp. rose $2.67 or 2.8 percent, to $97.43.

  • Final Glance: Biotechnology companies Wednesday, 22 Oct 2014 | 6:09 PM ET

    Amgen Inc. fell$. 45 or. 3 percent, to $143.64. Biogen Idec fell $17.70 or 5.4 percent, to $309.07. Celgene Corp. fell$. 21 or. 2 percent, to $94.76.

  • Midday Glance: Biotechnology companies Wednesday, 22 Oct 2014 | 1:18 PM ET

    Amgen Inc. fell $1.59 or 1.1 percent, to $142.50. Biogen Idec fell $23.54 or 7.2 percent, to $303.23. Celgene Corp. fell$. 60 or. 6 percent, to $94.37.

  • Early Glance: Biotechnology companies Wednesday, 22 Oct 2014 | 10:36 AM ET

    Amgen Inc. fell $1.16 or. 8 percent, to $142.93. Biogen Idec fell $21.61 or 6.6 percent, to $305.16. Celgene Corp. rose $1.23 or 1.3 percent, to $96.20.

  • Third Point urges Amgen to consider breakup Tuesday, 21 Oct 2014 | 7:31 PM ET

    A hedge fund run by a famed investor said Tuesday it has taken a large stake in Amgen and now wants the biotech drugmaker to consider splitting up into two. In response, Amgen said that its board and management are continually assessing the company's business. Third Point said Amgen Inc., which makes a range of drugs for arthritis, anemia and other diseases, is not...

  • Final Glance: Biotechnology companies Tuesday, 21 Oct 2014 | 6:01 PM ET

    Amgen Inc. rose $6.58 or 4.8 percent, to $144.09. Biogen Idec rose $15.36 or 4.9 percent, to $326.77. Celgene Corp. rose $2.97 or 3.2 percent, to $94.97.

  • BOSTON, Oct 21- Hedge fund manager Daniel Loeb told investors on Tuesday he urged U.S. biotechnology company Amgen Inc to split into two separate businesses, a move he said could boost its share price by more than 80 percent. "Our own extensive diligence suggests that a breakup of Amgen is feasible and that purported constraints such as tax strategy and supply...

  • 21,278%! 12 big winners from the '87 crash Tuesday, 21 Oct 2014 | 4:03 PM ET
    A trader on the New York Stock Exchange reacts on October 19, 1987 as stocks were devastated during one of the most frantic days in the exchange's history.

    There are 12 stocks that are up more than 10,000% since the 1987 Black Monday crash, reports USA Today.

  • Dan Loeb talks up Amgen stake; shares rise Tuesday, 21 Oct 2014 | 3:02 PM ET
    Daniel Loeb

    Hedge fund manager Dan Loeb recommended Amgen's stock Tuesday, causing shares to rise on the news.

  • Midday Glance: Biotechnology companies Tuesday, 21 Oct 2014 | 1:43 PM ET

    Amgen Inc. rose $1.96 or 1.4 percent, to $139.47. Biogen Idec rose $8.12 or 2.6 percent, to $319.53. Celgene Corp. rose $2.57 or 2.8 percent, to $94.57.

  • Early Glance: Biotechnology companies Tuesday, 21 Oct 2014 | 11:56 AM ET

    Amgen Inc. rose $1.55 or 1.1 percent, to $139.06. Biogen Idec rose $6.48 or 2.1 percent, to $317.89. Celgene Corp. rose $3.34 or 3.6 percent, to $95.34.

  • Final Glance: Biotechnology companies Monday, 20 Oct 2014 | 6:05 PM ET

    Amgen Inc. rose $3.82 or 2.9 percent, to $137.51. Biogen Idec rose $4.70 or 1.5 percent, to $311.41. Celgene Corp. rose $3.88 or 4.4 percent, to $92.00.

  • Midday Glance: Biotechnology companies Monday, 20 Oct 2014 | 1:23 PM ET

    Amgen Inc. rose$. 35 or. 3 percent, to $134.04. Biogen Idec rose $3.41 or 1.1 percent, to $310.12. Celgene Corp. rose $3.24 or 3.7 percent, to $91.36.

  • Early Glance: Biotechnology companies Monday, 20 Oct 2014 | 10:40 AM ET

    Amgen Inc. rose$. 93 or. 7 percent, to $134.62. Biogen Idec rose $2.07 or. 7 percent, to $308.78. Celgene Corp. rose $1.72 or 2.0 percent, to $89.84.